Skip header and navigation

4 records – page 1 of 1.

Systemic Therapy

https://libcat.nshealth.ca/en/permalink/chpams37341
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0010
Available Online
View Pamphlet
Systemic therapy includes chemotherapy drugs, hormones, and biological therapies. This type of cancer treatment treats the whole body rather than one part of it. This pamphlet details how systemic therapy works, how it is given, how long the treatment can last, and the side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Neoplasms - drug therapy
Subjects (LCSH)
Cancer--Chemotherapy
Combined modality therapy
Specialty
Medical Oncology
Pharmacy
Therapeutics
Abstract
Systemic therapy includes chemotherapy drugs, hormones, and biological therapies. This type of cancer treatment treats the whole body rather than one part of it. This pamphlet details how systemic therapy works, how it is given, how long the treatment can last, and the side effects.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0010
Less detail

Risankizumab (Skyrizi®) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams38191
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2345
Available Online
View Pamphlet
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
2345
Less detail

Nova Scotia Eating Disorder Provincial Service

https://libcat.nshealth.ca/en/permalink/chpams38242
Nova Scotia Health Authority. Nova Scotia Eating Disorder Provincial Service. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2381
Available Online
View Pamphlet
The Nova Scotia Eating Disorder Provincial Service (NSEDPS) treats people of all ages who have an eating disorder (like anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorder, and other eating disorders) and live in Nova Scotia. This pamphlet explains what an eating disorder is and how to access the NSEDPS. It gives information for children and adolescents, as well as adults. This pamphlet is also available as IWK Health Centre Patient Learning numbe…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Eating Disorder Provincial Service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Anorexia Nervosa
Bulimia Nervosa
Subjects (LCSH)
Eating disorders--Treatment
Abstract
The Nova Scotia Eating Disorder Provincial Service (NSEDPS) treats people of all ages who have an eating disorder (like anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorder, and other eating disorders) and live in Nova Scotia. This pamphlet explains what an eating disorder is and how to access the NSEDPS. It gives information for children and adolescents, as well as adults. This pamphlet is also available as IWK Health Centre Patient Learning number PL-1332.
Responsibility
Prepared by: Nova Scotia Eating Disorder Provincial Service
Pamphlet Number
2381
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1445
Available Online
View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Notes
Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail